Storm Therapeutics logo

Storm Therapeutics

Small molecule inhibitors of RNA-modifying enzymes for the treatment of cancer

4

Funding Rounds

$101.6m

Money raised

Overview

Small molecule inhibitors of RNA-modifying enzymes for the treatment of cancer

Funding

Funding series

Funding Series Analysis

The company Storm Therapeutics has raised a total of $77.8m in funding over 4 rounds.

Key Insights:

  • Storm Therapeutics December 2022 Series B Funding Round: $30m
  • Storm Therapeutics - Series B round, December 2022: $30m
  • Storm Therapeutics Series A round, May 2019: $17.8m
  • Storm Therapeutics funding round, January 2018: $5.4m
Storm Therapeutics logo
Storm Therapeutics December 2022 Series B Funding Round $30m
Storm Therapeutics logo
Storm Therapeutics - Series B round, December 2022 $30m
Storm Therapeutics logo
Storm Therapeutics Series A round, May 2019 $17.8m
Storm Therapeutics logo
Storm Therapeutics funding round, January 2018 $5.4m